Odefsey 200 mg/25 mg/25 mg Film-coated Tablets
Condition : New
0
From UAE
To United States
in 5-10 days
Description
How it Works:
Odefsey works by inhibiting the replication of the human immunodeficiency virus (HIV) in the body. Emtricitabine and tenofovir alafenamide are nucleoside reverse transcriptase inhibitors (NRTIs), which block an enzyme called reverse transcriptase that HIV needs to replicate. Rilpivirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI) that works similarly to inhibit HIV replication.Side Effects:
- Nausea
- Diarrhea
- Headache
- Fatigue
- Insomnia
Indications:
- Treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg
- Maintenance treatment of HIV-1 infection in virologically suppressed adults
Contraindications:
- Hypersensitivity to any components of Odefsey
- Coadministration with drugs that are strong inducers of CYP3A (may reduce the efficacy of rilpivirine)
- Coadministration with drugs that increase gastric pH (may reduce the absorption of tenofovir alafenamide)
- Severe renal impairment (creatinine clearance <30 mL/min)
- Breastfeeding (due to the potential for HIV transmission and adverse reactions)
Price Comparison:
Country | Price (in local currency) | Reference |
---|---|---|
United States | $2,400.00 | GoodRx |
United Kingdom | ?517.80 | NHS |
Australia | AUD 2,118.26 | Pharmaceutical Benefits Scheme (PBS) |
Canada | CAD 2,380.75 | DrugBank |
India | INR 8,895.00 | Medlife |
Top 5 Global Brands:
- Gilead Sciences (Manufacturer of Odefsey)
- ViiV Healthcare
- Bristol Myers Squibb
- Merck & Co.
- AbbVie
Related products
-
Uncategorized
Ivermectin: An Effective Antiparasitic Drug for Various Infections
Rated 0 out of 5Get Price